Company: NTWK
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001493152-25-021835
Chunk: 32

Company: NETSOL TECHNOLOGIES INC
Filing Date: 2025-11-12
Form: 10-Q
Item: Part I, Item 1
Chunk 32
---
 September 30, 2025, the Company issued 5,861 shares of common stock to a consultant pursuant to the terms of his
consultancy agreement. The grant date fair value of the shares was $25,000 and was recorded as compensation expense in the accompanying
consolidated financial statements.

During
the three months ended September 30, 2025, the Company issued 20,000 shares of common stock to employees pursuant to the terms of their
employment agreements. The grant date fair value was $84,400 and was recorded as compensation expense in the accompanying consolidated
financial statements.

Stock
Grants

The
following table summarizes stock grants awarded as compensation:

 SUMMARY OF UNVESTED STOCK GRANTS AWARDED AS COMPENSATION

    # Number of
                                                                               shares  
    Weighted Average
                                                                               Grant Date Fair
                                                                               Value ($) 
  
    Unvested, June 30, 2025 
     -  
    $                - 
  
    Granted 
     33,442  
    $4.35 
  
    Vested 
     (33,442) 
    $4.35 
  
    Unvested, September 30, 2025 
     -  
    $- 

For
the three months ended September 30, 2025 and 2024, the Company recorded compensation expense of $145,400 and $39,750, respectively.
The weighted average grant date fair value is determined by the Company’s closing stock price on the grant date.

    Page 23

NETSOL
TECHNOLOGIES, INC.

Notes
to Condensed Consolidated Financial Statements

September
30, 2025

(Unaudited)

NOTE
14 – INCENTIVE AND NON-STATUTORY STOCK OPTION PLAN

Common
stock purchase options consisted of the following:

OPTIONS:

SCHEDULE OF COMMON STOCK PURCHASE OPTIONS 

    # of shares  
    Weighted Average
                                                                               Exercise
Price  
    Weighted Average
                                                                               Remaining
                                                                               Contractual
                                                                               Life (in years)  
    Aggregated
                                                                               Intrinsic Value 

    Outstanding and exercisable, June 30, 2025 
     50,000  
    $          2.94  
     1.89  
     - 
  
    Granted 
     -  
     -  
     -